Key Issues Optical clocks Prototype funding SPAFORGEN
CSRA said this week sales in its most recent quarter reached nearly $1.3 billion, up about 30 percent from the same period a year earlier. The increase reflected the company's merger with SRA International.
Quarterly revenue was down 4 percent when accounting for SRA sales, the company said.
The company's quarterly profit hit $76 million, up from $48 million the prior year.